bluebird bio Inc (BLUE)
7.79
-0.64
(-7.59%)
USD |
NASDAQ |
Dec 23, 14:14
bluebird bio Total Liabilities (Quarterly): 470.84M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 6.609B |
| AIM ImmunoTech Inc | 10.68M |
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 465.06M |
| Shareholders Equity (Quarterly) | -5.786M |
| Debt to Equity Ratio | -12.20 |
| Current Ratio | 0.5094 |
| Net Debt Paydown Yield | -14.02% |